Remove Assay Development Remove Biochemical Assays Remove Production
article thumbnail

High Throughput Screening (HTS)

Sygnature Discovery

Compounds are drug-like with high chirality and FSP3 and the library contains novel natural product inspired scaffolds. The process begins with assay development or transfer. Our HTS group then conducts a robust, reliable assay validation screen (pilot).

article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. We often screen using a biochemical assay, but we can conduct cell-based screening as well. We need to build the assays that we need for compound screening.